Changhua Chemical Technology Co., Ltd. (SHE:301518)
China · Delayed Price · Currency is CNY 24.62
0.00 (0.00%)
At close: Oct 8, 2026
SHE:301518 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Revenue | 3,091 | 2,725 | 3,010 | 2,696 | 2,304 | 3,010 |
Other Revenue | 30.61 | 29.96 | 40.15 | 15.82 | 8.6 | 18.64 |
| 3,122 | 2,755 | 3,050 | 2,712 | 2,312 | 3,028 | |
Revenue Growth | 10.73% | -9.67% | 12.47% | 17.27% | -23.64% | 61.17% |
Cost of Revenue | 2,979 | 2,547 | 2,919 | 2,496 | 2,153 | 2,846 |
Gross Profit | 142.56 | 207.6 | 131.09 | 215.38 | 159.27 | 181.92 |
Selling, General & Admin | 106.98 | 85.75 | 71.56 | 68.24 | 48.07 | 47.28 |
Research & Development | 25.73 | 25.16 | 20.24 | 11.54 | 6.71 | 6.61 |
Other Operating Expenses | -1.23 | -8.32 | -15.02 | 3.16 | 4.75 | 4.44 |
Operating Expenses | 132.72 | 102.3 | 78.29 | 84.7 | 56.8 | 58.95 |
Operating Income | 9.84 | 105.31 | 52.8 | 130.67 | 102.47 | 122.97 |
Interest Expense | -7.96 | -1.41 | -1.6 | -2.07 | -4.72 | -9.84 |
Interest & Investment Income | 1.73 | 3.74 | 7.84 | 4.97 | 0.98 | 0.62 |
Currency Exchange Gain (Loss) | -3.53 | 0.37 | 4.37 | 1.9 | -0.62 | -1.13 |
Other Non Operating Income (Expenses) | -1.12 | -1.02 | -0.84 | -0.4 | -0.2 | -0.32 |
EBT Excluding Unusual Items | -1.04 | 106.99 | 62.56 | 135.07 | 97.91 | 112.3 |
Gain (Loss) on Sale of Investments | -0.07 | -0.25 | 0.25 | 0.68 | - | - |
Gain (Loss) on Sale of Assets | -0.19 | -0.13 | 0.18 | - | - | - |
Asset Writedown | -0.01 | -0.01 | -0 | -2.24 | -0 | -0.01 |
Other Unusual Items | 4.76 | 2.98 | 1.57 | 1.51 | 9.64 | 2.33 |
Pretax Income | 3.45 | 109.58 | 64.56 | 135.03 | 107.55 | 114.61 |
Income Tax Expense | -11.58 | 12.37 | 6.39 | 18.86 | 18.12 | 26.87 |
Earnings From Continuing Operations | 15.03 | 97.22 | 58.17 | 116.17 | 89.43 | 87.74 |
Minority Interest in Earnings | -0 | -0 | -0.02 | -0.09 | -0.05 | -0.19 |
Net Income | 15.03 | 97.22 | 58.16 | 116.08 | 89.38 | 87.55 |
Net Income to Common | 15.03 | 97.22 | 58.16 | 116.08 | 89.38 | 87.55 |
Net Income Growth | -79.69% | 67.17% | -49.90% | 29.87% | 2.09% | 19.83% |
Shares Outstanding (Basic) | 146 | 141 | 142 | 120 | 105 | 105 |
Shares Outstanding (Diluted) | 146 | 141 | 142 | 120 | 105 | 105 |
Shares Change | 3.92% | -0.67% | 18.53% | 13.80% | 0.02% | - |
EPS (Basic) | 0.10 | 0.69 | 0.41 | 0.97 | 0.85 | 0.83 |
EPS (Diluted) | 0.10 | 0.69 | 0.41 | 0.97 | 0.85 | 0.83 |
EPS Growth | -80.46% | 68.29% | -57.73% | 14.12% | 2.41% | 20.29% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -1,100 | -694.85 | -313.22 | 11.5 | 129.99 | 91.21 |
Free Cash Flow Per Share | -7.55 | -4.93 | -2.21 | 0.10 | 1.24 | 0.87 |
Dividend Per Share | 0.269 | 0.269 | 0.167 | 0.500 | - | - |
Dividend Growth | 61.08% | 61.08% | -66.60% | - | - | - |
Gross Margin | 4.57% | 7.54% | 4.30% | 7.94% | 6.89% | 6.01% |
Operating Margin | 0.32% | 3.82% | 1.73% | 4.82% | 4.43% | 4.06% |
Profit Margin | 0.48% | 3.53% | 1.91% | 4.28% | 3.86% | 2.89% |
Free Cash Flow Margin | -35.24% | -25.22% | -10.27% | 0.42% | 5.62% | 3.01% |
EBITDA | 89.45 | 153.27 | 100.66 | 166.02 | 144.86 | 167.29 |
EBITDA Margin | 2.87% | 5.56% | 3.30% | 6.12% | 6.26% | 5.52% |
D&A For EBITDA | 79.61 | 47.96 | 47.87 | 35.35 | 42.4 | 44.32 |
EBIT | 9.84 | 105.31 | 52.8 | 130.67 | 102.47 | 122.97 |
EBIT Margin | 0.32% | 3.82% | 1.73% | 4.82% | 4.43% | 4.06% |
Effective Tax Rate | - | 11.29% | 9.90% | 13.97% | 16.85% | 23.45% |
Revenue as Reported | 3,122 | 2,755 | 3,050 | 2,712 | 2,312 | 3,028 |
Advertising Expenses | - | 1.19 | 1.85 | 1.43 | 0.07 | - |